Undisclosed PDC Program(s)

About Ousia Pharma

Ousia Pharma is a private, preclinical-stage biotech leveraging a proprietary peptide-drug conjugate platform to target appetite-controlling brain regions for the treatment of cardiometabolic diseases. The company boasts a strong founding team with deep expertise in neuroscience, metabolism, and medicinal chemistry, and is supported by a high-caliber board with significant industry and investment experience. While still in early development and pre-revenue, Ousia is positioned to address the massive, unmet need in obesity and related metabolic disorders with a potentially safer and more targeted approach than current therapies.

Therapeutic Areas